GlassScriptPhysician profile
Abha R Amin
NPI 1023105608
$31,148.34
in general payments reported to CMS, 2019-2025
26 companies · $1,714 in 2025
The $1,714 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $912 · 2020: $446 · 2021: $740 · 2022: $1,630 · 2023: $8,884 · 2024: $17K · 2025: $1,714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,577 · Food and Beverage: $8,038 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,900 · Travel and Lodging: $1,755 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,577.00 |
| Food and Beverage | $8,037.68 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,900.00 |
| Travel and Lodging | $1,755.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $21,342.47 | 2022-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Envista Aspire Iol |
| Alcon Vision LLC | $2,137.98 | 2019-2025 | Ngenuity, Clareon, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $1,172.41 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Glaukos Corporation | $1,124.69 | 2023-2025 | Idosetr, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Thea Pharma INC. | $975.00 | 2023 | Iyuzeh |
| New World Medical,INC. | $937.50 | 2021-2023 | |
| Abbvie INC. | $776.25 | 2022-2023 | Xen Glaucoma Treatment System, Durysta |
| Allergan, INC. | $462.64 | 2020-2022 | |
| Carl Zeiss Meditec USA, INC. | $383.06 | 2021-2025 | Artevo 800 |
| Carl Zeiss Meditec, INC. | $324.51 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $311.44 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $258.45 | 2021-2022 | |
| Harrow Eye, LLC | $173.74 | 2023-2025 | Iheezo |
| Sight Sciences, INC. | $146.84 | 2024 | Omni Surgical System |
| Ivantis, INC | $141.31 | 2020-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $117.74 | 2021 | |
| Aerie Pharmaceuticals, INC. | $101.37 | 2021 | |
| Rxsight INC | $62.73 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Apellis Pharmaceuticals, INC. | $44.28 | 2025 | Syfovre |
| Biotissue Holdings INC. | $32.41 | 2022 | |
| Nova Eye, INC. | $26.79 | 2025 | |
| Novartis Pharmaceuticals Corporation | $24.96 | 2020 | |
| Dompe US, INC. | $24.50 | 2025 | Oxervate |
| Ocular Therapeutix, INC. | $16.99 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.88 | 2020 | |
| Iridex Corporation | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abha Amin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.